Stocks and Investing Stocks and Investing
Thu, August 10, 2023

Robert Burns Maintained (BNTX) at Strong Buy with Decreased Target to $180 on, Aug 10th, 2023


Published on 2024-10-28 05:47:27 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Maintained "BioNTech SE" (BNTX) at Strong Buy with Decreased Target from $181 to $180 on, Aug 10th, 2023.

Robert has made no other calls on BNTX in the last 4 months.



There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 3 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Korn of "Morgan Stanley" Maintained at Hold with Decreased Target to $116 on, Tuesday, August 8th, 2023
  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold with Decreased Target to $120 on, Thursday, May 18th, 2023
  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $128 on, Monday, April 10th, 2023


These are the ratings of the 3 analyists that currently disagree with Robert


  • Rajesh Kumar of "HSBC" Initiated at Strong Buy and Held Target at $124 on, Friday, July 14th, 2023
  • Bill Selesky of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $203 on, Friday, June 16th, 2023
  • Simon Baker of "Redburn Partners" Upgraded from Hold to Strong Buy and Increased Target to $170 on, Wednesday, May 17th, 2023
Contributing Sources